top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

PLRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,466,297.00

Pliant Therapeutics Insider Trading History Chart

Pliant Therapeutics Share Price & Price History

^$11.90

▼ -0.62 (-4.95%)

As of 04/24/2024 01:00 AM ET

Days: 30 | 90 | 365

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

From Traders Agency | Ad

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Pliant Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/17/2024	Bernard Coulie	CEO	Sell	25,721	$17.23	$443,172.83	316,382
1/17/2024	Hans Hull	Insider	Sell	9,786	$17.23	$168,612.78	185,069
1/17/2024	Keith Lamont Cummings	CFO	Sell	9,781	$17.23	$168,526.63	194,605
1/17/2024	Mike Ouimette	General Counsel	Sell	5,197	$17.23	$89,544.31	55,246
8/3/2023	Hans Hull	Insider	Sell	13,069	$20.00	$261,380.00	206,114
7/20/2023	Mike Ouimette	General Counsel	Sell	4,755	$17.55	$83,450.25	60,443
7/17/2023	Bernard Coulie	CEO	Sell	70,150	$18.01	$1,263,401.50	342,103
7/17/2023	Eric Lefebvre	Insider	Sell	22,321	$18.01	$402,001.21	167,215
7/17/2023	Keith Lamont Cummings	CFO	Sell	19,771	$18.01	$356,075.71	203,999
7/17/2023	Mike Ouimette	General Counsel	Sell	12,778	$18.01	$230,131.78	65,198
4/3/2023	Mike Ouimette	General Counsel	Sell	2,877	$26.79	$77,074.83	50,789
3/30/2023	Bernard Coulie	CEO	Sell	35,339	$26.52	$937,190.28	274,753
3/30/2023	Eric Lefebvre	Insider	Sell	11,245	$26.52	$298,217.40	145,786
3/30/2023	Keith Lamont Cummings	CFO	Sell	9,960	$26.52	$264,139.20	148,470
3/30/2023	Mike Ouimette	General Counsel	Sell	4,874	$26.52	$129,258.48	53,666
2/3/2023	Bernard Coulie	CEO	Sell	15,000	$33.61	$504,150.00	240,112
1/31/2023	Bernard Coulie	CEO	Sell	15,000	$34.92	$523,800.00	240,112
1/26/2023	Bernard Coulie	CEO	Sell	15,000	$35.29	$529,350.00	240,112
1/24/2023	Bernard Coulie	CEO	Sell	15,000	$30.89	$463,350.00	93,812
1/23/2023	Eric Lefebvre	Insider	Sell	67,500	$34.48	$2,327,400.00	76,926
1/23/2023	Keith Lamont Cummings	CFO	Sell	30,000	$35.00	$1,050,000.00	84,424
1/23/2023	Mike Ouimette	General Counsel	Sell	20,000	$34.19	$683,800.00	5,947
1/9/2023	Bernard Coulie	CEO	Sell	5,000	$19.17	$95,850.00	93,812
1/6/2023	Bernard Coulie	CEO	Sell	15,000	$19.04	$285,600.00	93,812
1/3/2023	Bernard Coulie	CEO	Sell	15,000	$19.33	$289,950.00	93,812
12/22/2022	Mike Ouimette	General Counsel	Sell	2,928	$19.38	$56,744.64	5,947
12/20/2022	Bernard Coulie	CEO	Sell	34,212	$19.10	$653,449.20	93,812
12/20/2022	Eric Lefebvre	Insider	Sell	10,887	$19.10	$207,941.70	144,426
12/20/2022	Keith Lamont Cummings	CFO	Sell	9,643	$19.10	$184,181.30	80,424
12/20/2022	Mike Ouimette	General Counsel	Sell	4,719	$19.10	$90,132.90	8,875
10/25/2022	Eric Lefebvre	Insider	Sell	5,000	$25.05	$125,250.00	133,437
9/12/2022	Bernard Coulie	CEO	Sell	12,502	$22.54	$281,795.08	59,273
7/11/2022	Bernard Coulie	CEO	Sell	15,000	$22.50	$337,500.00	59,273
7/11/2022	Eric Lefebvre	Insider	Sell	3,000	$20.00	$60,000.00	138,436
6/18/2021	Eric Lefebvre	Insider	Sell	12,500	$28.87	$360,875.00	140,830
6/14/2021	Bernard Coulie	CEO	Sell	4,000	$33.03	$132,120.00	54,840
5/14/2021	Bernard Coulie	CEO	Sell	3,500	$28.64	$100,240.00	54,840

Fed launches fourth dollar overhaul

From Stansberry Research | Ad

You've likely heard a million different warnings about the changes taking place in America's financial system right now... How the White House plans to take the dollar fully digital???

Just click here now for the full story.

SEC Filings (Institutional Ownership Changes) for Pliant Therapeutics (NASDAQ:PLRX)

97.30% of Pliant Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Pliant Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/4/2024	Mass General Brigham Inc	288,690	$4.30M	7.5%	N/A	0.479%
2/15/2024	Great Point Partners LLC	1,823,184	$33.02M	5.6%	+3.9%	3.044%
2/15/2024	Granahan Investment Management LLC	1,150,766	$20.84M	0.7%	+22.5%	1.921%
2/14/2024	First Light Asset Management LLC	3,591,776	$65.05M	5.2%	+22.4%	5.997%
2/13/2024	Rhenman & Partners Asset Management AB	112,741	$2.04M	0.2%	-65.9%	0.188%
2/9/2024	Franklin Resources Inc.	1,579,572	$28.61M	0.0%	+4.1%	2.637%
2/9/2024	Quest Partners LLC	2,051	$37K	0.0%	N/A	0.003%
2/9/2024	UBS Group AG	342,173	$6.20M	0.0%	+26.4%	0.571%
2/7/2024	Teacher Retirement System of Texas	10,232	$0.19M	0.0%	-14.5%	0.017%
2/6/2024	Charles Schwab Investment Management Inc.	424,196	$7.68M	0.0%	+1.4%	0.708%
2/6/2024	Swiss National Bank	88,400	$1.60M	0.0%	-3.0%	0.148%
2/5/2024	Fernwood Investment Management LLC	423,177	$7.66M	1.9%	+11.4%	0.706%
2/5/2024	Russell Investments Group Ltd.	60,001	$1.09M	0.0%	-43.8%	0.100%
2/1/2024	New York State Common Retirement Fund	55,748	$1.01M	0.0%	+10.2%	0.093%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	5,600	$0.10M	0.0%	-24.9%	0.009%
1/24/2024	Arizona State Retirement System	12,545	$0.23M	0.0%	+6.4%	0.021%
1/24/2024	China Universal Asset Management Co. Ltd.	6,929	$0.13M	0.0%	+353.2%	0.012%
1/23/2024	HighMark Wealth Management LLC	23,500	$0.43M	0.3%	N/A	0.039%
12/18/2023	Vanguard Group Inc.	2,945,312	$51.07M	0.0%	+6.1%	4.917%
12/6/2023	Citigroup Inc.	13,526	$0.24M	0.0%	-44.3%	0.023%
11/24/2023	Deutsche Bank AG	985,569	$17.09M	0.0%	-23.6%	1.645%
11/22/2023	Polar Capital Holdings Plc	1,665,000	$28.87M	0.2%	+1.5%	2.780%
11/15/2023	GSA Capital Partners LLP	45,587	$0.79M	0.1%	N/A	0.076%
11/15/2023	Laurion Capital Management LP	3,186,511	$55.25M	0.3%	+0.9%	5.320%
11/14/2023	Corton Capital Inc.	11,339	$0.20M	0.1%	N/A	0.019%
11/14/2023	Fred Alger Management LLC	116,005	$2.01M	0.0%	+7.3%	0.194%
11/14/2023	Trexquant Investment LP	42,277	$0.73M	0.0%	+111.7%	0.071%
11/14/2023	Profund Advisors LLC	12,405	$0.22M	0.0%	N/A	0.021%
11/13/2023	Rathbones Group PLC	11,700	$0.20M	0.0%	N/A	0.020%
11/13/2023	Silverarc Capital Management LLC	250,409	$4.34M	1.3%	+133.4%	0.419%
11/13/2023	FMR LLC	4,141,004	$71.81M	0.0%	-2.4%	6.921%
11/13/2023	Rhenman & Partners Asset Management AB	330,635	$5.73M	0.6%	N/A	0.553%
11/9/2023	Rhenman & Partners Asset Management AB	330,635	$5.73M	0.4%	N/A	0.553%
11/9/2023	Deutsche Bank AG	985,569	$17.09M	0.0%	-23.6%	1.647%
11/9/2023	UBS Group AG	270,804	$4.70M	0.0%	+8,855.2%	0.453%
11/8/2023	Charles Schwab Investment Management Inc.	418,206	$7.25M	0.0%	+17.2%	0.699%
11/8/2023	Swiss National Bank	91,100	$1.58M	0.0%	-5.3%	0.152%
11/8/2023	Oppenheimer & Co. Inc.	12,135	$0.21M	0.0%	N/A	0.020%
11/7/2023	Quantbot Technologies LP	32,735	$0.57M	0.0%	+26.2%	0.055%
11/7/2023	New York State Common Retirement Fund	50,575	$0.88M	0.0%	+3.5%	0.085%
11/7/2023	Barclays PLC	244,266	$4.24M	0.0%	+165.3%	0.408%
11/7/2023	Jump Financial LLC	78,768	$1.37M	0.1%	-23.9%	0.132%
10/31/2023	China Universal Asset Management Co. Ltd.	1,529	$27K	0.0%	+97.3%	0.003%
10/27/2023	TD Asset Management Inc	112,248	$1.95M	0.0%	+100.0%	0.188%
10/24/2023	Bank of New York Mellon Corp	200,224	$3.47M	0.0%	+8.4%	0.335%
8/15/2023	Readystate Asset Management LP	55,941	$1.01M	0.1%	N/A	0.093%
8/15/2023	Silverarc Capital Management LLC	107,267	$1.94M	0.6%	-64.2%	0.179%
8/14/2023	Casdin Capital LLC	1,700,000	$30.80M	2.7%	+1.5%	2.841%
8/14/2023	ArrowMark Colorado Holdings LLC	281,189	$5.10M	0.1%	N/A	0.470%
8/14/2023	Great Point Partners LLC	1,550,184	$28.09M	5.5%	+27.9%	2.591%
8/14/2023	Artia Global Partners LP	100,000	$1.81M	0.6%	N/A	0.167%
8/14/2023	UniSuper Management Pty Ltd	140,000	$2.54M	0.0%	N/A	0.234%
8/14/2023	Deep Track Capital LP	4,050,000	$73.39M	3.4%	+18.3%	6.769%
8/14/2023	Polar Capital Holdings Plc	1,640,000	$29.72M	0.2%	-8.0%	2.741%
8/14/2023	Granahan Investment Management LLC	810,357	$14.68M	0.5%	+56.1%	1.354%
8/14/2023	Prelude Capital Management LLC	13,206	$0.24M	0.0%	N/A	0.022%
8/11/2023	VR Adviser LLC	288,949	$5.24M	0.8%	-79.8%	0.488%
8/11/2023	Franklin Resources Inc.	1,500,324	$27.19M	0.0%	+0.7%	2.536%
8/11/2023	Trexquant Investment LP	19,969	$0.36M	0.0%	-53.9%	0.034%
8/11/2023	Capital International Investors	912,467	$16.53M	0.0%	N/A	1.542%
8/11/2023	Artal Group S.A.	1,490	$27K	0.0%	-99.4%	0.003%
8/11/2023	ExodusPoint Capital Management LP	20,220	$0.37M	0.0%	+35.0%	0.034%
8/10/2023	Bessemer Group Inc.	532,079	$9.64M	0.0%	+0.2%	0.899%
8/10/2023	TRV GP Iii LLC	339,160	$6.15M	33.7%	-81.6%	0.573%
8/10/2023	Metropolitan Life Insurance Co NY	3,089	$56K	0.0%	N/A	0.005%
8/10/2023	ProShare Advisors LLC	11,177	$0.20M	0.0%	N/A	0.019%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	27,205	$0.49M	0.0%	N/A	0.046%
8/10/2023	Russell Investments Group Ltd.	96,601	$1.75M	0.0%	-46.1%	0.163%
8/9/2023	TD Asset Management Inc	56,124	$1.02M	0.0%	+10.4%	0.095%
8/9/2023	Swiss National Bank	96,200	$1.74M	0.0%	+4.0%	0.163%
8/8/2023	Rhumbline Advisers	78,842	$1.43M	0.0%	N/A	0.133%
8/8/2023	Candriam S.C.A.	265,000	$4.80M	0.0%	+10.4%	0.448%
8/4/2023	American International Group Inc.	27,195	$0.49M	0.0%	N/A	0.046%
8/3/2023	Jennison Associates LLC	50,824	$0.92M	0.0%	-95.9%	0.086%
8/3/2023	Innovis Asset Management LLC	13,762	$0.25M	0.1%	N/A	0.023%
8/3/2023	Bank of New York Mellon Corp	184,646	$3.35M	0.0%	+627.3%	0.312%
8/1/2023	Fiduciary Trust Co.	11,620	$0.21M	0.0%	+45.3%	0.020%
7/27/2023	Victory Capital Management Inc.	23,479	$0.43M	0.0%	-94.1%	0.040%
7/27/2023	Virtu Financial LLC	48,037	$0.87M	0.1%	+425.0%	0.081%
7/25/2023	DekaBank Deutsche Girozentrale	40,000	$0.74M	0.0%	+33.3%	0.068%
7/19/2023	Teacher Retirement System of Texas	11,988	$0.22M	0.0%	-9.1%	0.020%
5/16/2023	First Light Asset Management LLC	1,425,354	$37.91M	3.4%	+34.7%	2.409%
5/16/2023	Great Point Partners LLC	1,212,096	$32.24M	6.3%	-8.4%	2.049%
5/16/2023	Harvard Management Co. Inc.	281,189	$7.48M	0.8%	-50.0%	0.475%
5/15/2023	Atom Investors LP	22,872	$0.61M	0.3%	-42.0%	0.039%
5/15/2023	Granahan Investment Management LLC	518,965	$13.80M	0.4%	+2.7%	0.877%
5/12/2023	Mirabella Financial Services LLP	28,640	$0.76M	0.1%	+152.5%	0.048%
5/12/2023	HRT Financial LP	165,512	$4.40M	0.1%	N/A	0.280%
5/11/2023	CHI Advisors LLC	3,001,835	$79.85M	21.2%	-6.2%	5.074%
5/11/2023	FMR LLC	4,531,515	$120.54M	0.0%	+3.1%	7.660%
5/11/2023	Skandinaviska Enskilda Banken AB publ	30,490	$0.81M	0.0%	N/A	0.052%
5/10/2023	Oppenheimer & Co. Inc.	7,667	$0.20M	0.0%	N/A	0.013%
5/10/2023	Landscape Capital Management L.L.C.	20,712	$0.55M	0.1%	-17.6%	0.035%
5/10/2023	Bessemer Group Inc.	530,896	$14.12M	0.0%	-4.3%	0.897%
5/10/2023	Swiss National Bank	92,500	$2.46M	0.0%	+5.0%	0.156%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	43,479	$1.16M	0.0%	N/A	0.073%
5/9/2023	California State Teachers Retirement System	37,616	$1M	0.0%	+18.6%	0.064%
5/9/2023	Y Intercept Hong Kong Ltd	11,829	$0.32M	0.0%	N/A	0.020%
5/4/2023	Barclays PLC	11,781	$0.31M	0.0%	-55.6%	0.020%
5/3/2023	Jump Financial LLC	65,867	$1.75M	0.1%	+53.6%	0.111%

Data available starting January 2016

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Today's Range

Now: $11.90

$11.73

$12.55

50 Day Range

MA: $14.90

$11.90

$17.21

52 Week Range

Now: $11.90

$11.73

$30.85

Volume

368,646 shs

Average Volume

382,172 shs

Market Capitalization

$716.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12

Who are the company insiders with the largest holdings of Pliant Therapeutics?: Pliant Therapeutics' top insider investors include:
Bernard Coulie (CEO)
Hans Hull (Insider)
Keith Lamont Cummings (CFO)
Eric Lefebvre (Insider)
Mike Ouimette (General Counsel)
Learn More about top insider investors at Pliant Therapeutics.
Who are the major institutional investors of Pliant Therapeutics?: Pliant Therapeutics' top institutional investors include:
Mass General Brigham Inc — 0.48%
Learn More about top institutional investors of Pliant Therapeutics stock.
Which major investors are buying Pliant Therapeutics stock?: In the last quarter, PLRX stock was bought by institutional investors including:
Mass General Brigham Inc

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

From Traders Agency | Ad

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

PLRX Insider Trading

Pliant Therapeutics Insider Trading History Chart

Pliant Therapeutics Share Price & Price History

Pliant Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Pliant Therapeutics (NASDAQ:PLRX)

Institutional Buying and Selling by Quarter

Pliant Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Pliant Therapeutics?

Who are the major institutional investors of Pliant Therapeutics?

Which major investors are buying Pliant Therapeutics stock?